FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Haraf

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Haraf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):769-76.
2013: D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Oral oncology 2013;49(3):277-82.
2012: Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Oral oncology 2012;48(10):1025-30.
2012: Kerstin M Stenson; Victoria Villaflor; Ezra E W Cohen; Elizabeth Blair; Daniel J Haraf; Rangesh Kunnavakkam; Ellen MacCracken; Louis D Portugal; Joseph K Salama; Tanguy Seiwert; Everett E Vokes
Chemoradiation for patients with large-volume laryngeal cancers.
Head & neck 2012;34(8):1162-7.
2012: Joseph K Salama; Walter M Stadler; Victoria M Villaflor; Everett E Vokes; Kamil M Yenice; Steven J Chmura; Ezra E W Cohen; Philip P Connell; Daniel J Haraf; Michael D Hasselle; Samuel Hellman; Philip C Hoffman; Renuka Malik; Neil Mehta; Ralph R Weichselbaum
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Cancer 2012;118(11):2962-70.
2012: Michael D Hasselle; Philip C Hoffman; Kyle E Rusthoven; Steven J Chmura; Philip P Connell; Daniel W Golden; Daniel J Haraf; Ravi Salgia; Niket Shah; Victoria M Villaflor; Everett E Vokes; Ralph R Weichselbaum; Joseph K Salama
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(2):376-81.
2011: D Shumway; W T Vigneswaren; V Villaflor; Ravi Salgia; Arif Y Shaikh; Philip P Connell; K Corbin; Mark K Ferguson; Daniel J Haraf; P Hoffman; R M Malik; Joseph K Salama
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):446-50.
2011: V M Villaflor; Everett E Vokes; R D Williams; Mary Ellyn Witt; P Beniwal; E A Blair; A J Dekker; G Gomez-Abuin; Daniel J Haraf; Masha Kocherginsky; Alexander Langerman; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Ezra E W Cohen
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2501-7.
2011: Kevin S Choe; Ezra E W Cohen; Daniel J Haraf; Louis Portugal; Tanguy Y Seiwert; Abhishek Solanki; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Joseph K Salama
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Cancer 2011;117(20):4671-8.
2011: Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; E A Blair; Ezra E W Cohen; Daniel J Haraf; R Kunnavakkam; R Williams; Mary Ellyn Witt; Everett E Vokes
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(10):2304-9.
2011: Aaron W Pederson; Joseph K Salama; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Daniel J Haraf
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
American journal of clinical oncology 2011;34(4):356-61.
2011: Aaron W Pederson; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Ezra E W Cohen; Daniel J Haraf; Elizabeth A Blair
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Head & neck oncology 2011;3():31.
2010: Kent W Mouw; Daniel J Haraf; Kerstin M Stenson; Ezra E Cohen; Xi Xi; Mary Ellyn Witt; Marcy List; Elizabeth A Blair; Everett E Vokes; Joseph K Salama
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2010;136(12):1226-34.
2010: Kevin S Choe; Joseph K Salama; Kerstin M Stenson; Elizabeth A Blair; Mary Ellyn Witt; Ezra E W Cohen; Daniel J Haraf; Everett E Vokes
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;97(2):318-21.
2010: Aaron W Pederson; Daniel J Haraf; Mary Ellyn Witt; Kerstin M Stenson; Everett E Vokes; Elizabeth A Blair; Joseph K Salama
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Head & neck 2010;32(11):1519-27.
2010: Ezra E W Cohen; Daniel J Haraf; Rangesh Kunnavakkam; Kerstin M Stenson; Elizabeth A Blair; Bruce E Brockstein; Eric P Lester; Joseph K Salama; Allison Dekker; Rosalyn Williams; Mary Ellyn Witt; Tatyana A Grushko; James J Dignam; Mark W Lingen; Olufunmilayo I Olopade; Everett E Vokes
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3336-43.
2010: Aaron W Pederson; Daniel J Haraf; Elizabeth A Blair; Kerstin M Stenson; Mary Ellyn Witt; Everett E Vokes; Joseph K Salama
Chemoreirradiation for recurrent salivary gland malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;95(3):308-11.
2010: Loren K Mell; James J Dignam; Joseph K Salama; Ezra E W Cohen; Blase N Polite; Virag Dandekar; Amit D Bhate; Mary Ellyn Witt; Daniel J Haraf; Bharat B Mittal; Everett E Vokes; Ralph R Weichselbaum
Predictors of competing mortality in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):15-20.
2010: Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph K Salama; Everett E Vokes
Chemoradiation for patients with advanced oral cavity cancer.
The Laryngoscope 2010;120(1):93-9.
2009: Alexander Langerman; Colleen Plein; Everett E Vokes; Joseph K Salama; Daniel J Haraf; Elizabeth A Blair; Kerstin M Stenson
Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2009;135(11):1133-6.
2009: Ezra E W Cohen; Joshua Baru; Dezheng Huo; Daniel J Haraf; Maureen Crowley; Mary Ellyn Witt; Elizabeth A Blair; Ralph R Weichselbaum; Fred Rosen; Everett E Vokes; Kerstin M Stenson
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Head & neck 2009;31(8):1013-21.
2008: Joseph K Salama; Kerstin M Stenson; Marcy A List; Loren K Mell; Ellen MacCracken; Ezra E W Cohen; Elizabeth Blair; Everett E Vokes; Daniel J Haraf
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2008;134(10):1060-5.
2008: Joseph K Salama; Kerstin M Stenson; Emily O Kistner; Bharat B Mittal; Athanassios Argiris; Mary Ellyn Witt; Fred R Rosen; Bruce E Brockstein; Ezra E W Cohen; Daniel J Haraf; Everett E Vokes
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1787-94.
2008: Nicholas W Choong; Ann M Mauer; Daniel J Haraf; Eric Lester; Philip C Hoffman; Mark F. Kozloff; Shang Lin; Janet E Dancey; Livia Szeto; Tatyana Grushko; Olufunmilayo I Olopade; Ravi Salgia; Everett E Vokes
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1003-11.
2008: B R Knab; Joseph K Salama; A Solanki; Kerstin M Stenson; Ezra E W Cohen; Mary Ellyn Witt; Daniel J Haraf; Everett E Vokes
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(9):1650-4.
2008: Joseph K Salama; Steven J Chmura; Neil Mehta; Kamil M Yenice; Walter M Stadler; Everett E Vokes; Daniel J Haraf; Samuel Hellman; Ralph R Weichselbaum
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5255-9.
2008: Alvin B Cohn; Patrick O Lang; Jayant P Agarwal; Stephanie L Peng; Kaveh Alizadeh; Kerstin M Stenson; Daniel J Haraf; Ezra E W Cohen; Everett E Vokes; Lawrence J Gottlieb
Free-flap reconstruction in the doubly irradiated patient population.
Plastic and reconstructive surgery 2008;122(1):125-32.
2008: Tanguy Seiwert; Daniel J Haraf; Ezra E W Cohen; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Masha Kocherginsky; Ralph R Weichselbaum; Helen X Chen; Everett E Vokes
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1732-41.
2008: Nicholas W Choong; Everett E Vokes; Daniel J Haraf; Peter K Tothy; Mark K Ferguson; Kristen Kasza; Charles Rudin; Philip C Hoffman; Stuart A Krauss; Livia Szeto; Ann M Mauer
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(1):59-67.
2007: Alexander Langerman; Ellen MacCracken; Kristen Kasza; Daniel J Haraf; Everett E Vokes; Kerstin M Stenson
Aspiration in chemoradiated patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2007;133(12):1289-95.
2007: Tanguy Seiwert; Ezra E W Cohen; Daniel J Haraf; Kerstin M Stenson; Elizabeth A Blair; Ann M Mauer; Allison Dekker; Everett E Vokes
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Cancer investigation 2007;25(6):435-44.
2007: Cathy L. Lazarus; Jeri A Logemann; Barbara Roa Pauloski; Alfred W Rademaker; Irene B Helenowski; Edward F Vonesh; Ellen MacCracken; Bharat B Mittal; Everett E Vokes; Daniel J Haraf
Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.
Head & neck 2007;29(7):632-7.
2007: Arif Y Shaikh; Daniel J Haraf; Joseph K Salama; Ravi Salgia; Philip C Hoffman; Mark K Ferguson; Philip P Connell
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
American journal of clinical oncology 2007;30(3):258-63.
2007: Ezra E W Cohen; Dominique Rosine; Daniel J Haraf; Elwyn Loh; Liji Shen; Antoine Lusinchi; Everett E Vokes; Jean Bourhis
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
International journal of radiation oncology, biology, physics 2007;67(3):678-84.
2007: Tanguy Seiwert; Philip P Connell; Ann M Mauer; Philip C Hoffman; Christopher M George; Livia Szeto; Ravi Salgia; Katherine E Posther; Binh Nguyen; Daniel J Haraf; Everett E Vokes
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):515-22.
2006: Ezra E W Cohen; Daniel J Haraf; Marcy A List; Masha Kocherginsky; Bharat B Mittal; Fred R Rosen; Bruce E Brockstein; Rosalyn Williams; Mary Ellyn Witt; Kerstin M Stenson; Merrill S Kies; Everett E Vokes
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3438-44.
2006: Michael T Milano; Everett E Vokes; Johnny Kao; Wells Jackson; Marcy A List; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Ellen MacCracken; Michael C Garofalo; Steven J Chmura; Ralph R Weichselbaum; Daniel J Haraf
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
International journal of oncology 2006;28(5):1141-51.
2006: Philip P Connell; Krishanthi Jayathilaka; Daniel J Haraf; Ralph R Weichselbaum; Everett E Vokes; Mark W Lingen
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
International journal of oncology 2006;28(5):1113-9.
2006: Joseph K Salama; Everett E Vokes; Steven J Chmura; Michael T Milano; Johnny Kao; Kerstin M Stenson; Mary Ellyn Witt; Daniel J Haraf
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2006;64(2):382-91.
2006: Kerstin M Stenson; Dezheng Huo; Elizabeth Blair; Ezra E W Cohen; Athanassios Argiris; Daniel J Haraf; E Everett Vokes
Planned post-chemoradiation neck dissection: significance of radiation dose.
The Laryngoscope 2006;116(1):33-6.
2006: Jeri A Logemann; Alfred W Rademaker; Barbara Roa Pauloski; Cathy L. Lazarus; Bharat B Mittal; Bruce E Brockstein; Ellen MacCracken; Daniel J Haraf; Everett E Vokes; Lisa A Newman; Dachao Liu
Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.
Head & neck 2006;28(1):64-73.
2005: Michael T Milano; Everett E Vokes; Joseph K Salama; Kerstin M Stenson; Johnny Kao; Mary Ellyn Witt; Bharat B Mittal; Athanassios Argiris; Ralph R Weichselbaum; Daniel J Haraf
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1096-106.
2005: Joseph K Salama; Daniel J Haraf; Kerstin M Stenson; Michael T Milano; Mary Ellyn Witt; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Cancer journal (Sudbury, Mass.) 2005;11(2):140-6.
2004: Steven J Chmura; Michael T Milano; Daniel J Haraf
Reirradiation of recurrent head and neck cancers with curative intent.
Seminars in oncology 2004;31(6):816-21.
2004: Neil Mehta; Ann M Mauer; Samuel Hellman; Daniel J Haraf; Ezra E W Cohen; Everett E Vokes; Ralph R Weichselbaum
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
International journal of oncology 2004;25(6):1677-83.
2004: Michael T Milano; Daniel J Haraf; Kerstin M Stenson; Mary Ellyn Witt; Cathy Eng; Bharat B Mittal; Athanassios Argiris; Harold Pelzer; Mark F. Kozloff; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):4922-32.
2004: Bruce E Brockstein; Daniel J Haraf; Alfred W Rademaker; Merrill S Kies; Kerstin M Stenson; Fred R Rosen; Bharat B Mittal; Harold Pelzer; B B Fung; Mary Ellyn Witt; Barry L Wenig; Louis Portugal; R W Weichselbaum; Everett E Vokes
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1179-86.
2004: Athanassios Argiris; Kerstin M Stenson; Bruce E Brockstein; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Prathima Jayaram; Louis Portugal; Barry L Wenig; Fred R Rosen; Daniel J Haraf; Everett E Vokes
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Head & neck 2004;26(5):447-55.
2004: Athanassios Argiris; Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; Bharat B Mittal; Merrill S Kies; Fred R Rosen; Borko Jovanovic; Everett E Vokes
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1956-62.
2003: Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Athanassios Argiris; Bharat B Mittal; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Louis Portugal; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5936-43.
2003: Bharat B Mittal; Barbara Roa Pauloski; Daniel J Haraf; Harold Pelzer; Athanassios Argiris; Everett E Vokes; Alfred Rademaker; Jeri A Logemann
Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
International journal of radiation oncology, biology, physics 2003;57(5):1219-30.
2003: Elizabeth B Lamont; Davinder Hayreh; Kate E Pickett; James J Dignam; Marcy A List; Kerstin M Stenson; Daniel J Haraf; Bruce E Brockstein; Sarah A Sellergren; Everett E Vokes
Is patient travel distance associated with survival on phase II clinical trials in oncology?
Journal of the National Cancer Institute 2003;95(18):1370-5.
2003: Athanassios Argiris; S M Smith; Kerstin M Stenson; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Daniel J Haraf; E E Vokes
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1306-11.
2003: Fred R Rosen; Daniel J Haraf; Merrill S Kies; Kerstin M Stenson; Louis Portugal; Marcy A List; Bruce E Brockstein; Bharat B Mittal; Alfred W Rademaker; Mary Ellyn Witt; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
2003: J L Oh; Everett E Vokes; Merrill S Kies; Bharat B Mittal; Mary Ellyn Witt; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):564-9.
2003: Johnny Kao; Michael C Garofalo; Michael T Milano; Steven J Chmura; Jason R Citron; Daniel J Haraf
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.
Cancer treatment reviews 2003;29(1):21-30.
2003: Everett E Vokes; Kerstin M Stenson; Fred R Rosen; Merrill S Kies; Alfred W Rademaker; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Bing Bing Fung; Louis Portugal; Bharat B Mittal; Harold Pelzer; Ralph R Weichselbaum; Daniel J Haraf
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
2003: Bruce E Brockstein; Arno J Mundt; Daniel J Haraf; Mark Ferguson; Anthony Montag
Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases.
Sarcoma 2003;7(3-4):167-72.
2003: Athanassios Argiris; Daniel J Haraf; Merrill S Kies; Everett E Vokes
Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
The oncologist 2003;8(4):350-60.
2002: Philip C Hoffman; Ezra E W Cohen; Gregory A Masters; Daniel J Haraf; Ann M Mauer; Charles Rudin; Stuart A Krauss; Dezheng Huo; Everett E Vokes
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):65-71.
2002: Marcy A List; Judith Lee Rutherford; John Stracks; Daniel J Haraf; Merrill S Kies; Everett E Vokes
An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.
Cancer 2002;95(1):98-104.
2002: Michael C Garofalo; Daniel J Haraf
Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer.
Current opinion in oncology 2002;14(3):330-3.
2001: Merrill S Kies; Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Marcy A List; Bruce E Brockstein; T Chung; Bharat B Mittal; Harold Pelzer; Louis Portugal; Alfred Rademaker; R Weichselbaum; Everett E Vokes
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1961-9.
2001: CA Mantz; Everett E Vokes; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):343-7.
2001: CA Mantz; Everett E Vokes; Kerstin M Stenson; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
2001: Christopher M George; Daniel J Haraf; Ann M Mauer; Stuart A Krauss; Philip C Hoffman; Charles Rudin; Livia Szeto; Everett E Vokes
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest.
Investigational new drugs 2001;19(4):303-10.
2001: Philip P Connell; L Ignacio; Daniel J Haraf; Azhar M. Awan; Howard J Halpern; Ibrahim Abdalla; J Nautiyal; Ashesh B Jani; Ralph R Weichselbaum; Srinivasan Vijayakumar
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):54-61.
2000: Everett E Vokes; Daniel J Haraf; Merrill S Kies
The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Seminars in oncology 2000;27(4 Suppl 8):34-8.
2000: Kerstin M Stenson; Daniel J Haraf; Harold Pelzer; Wendy Recant; Merrill S Kies; Ralph R Weichselbaum; Everett E Vokes
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
Archives of otolaryngology--head & neck surgery 2000;126(8):950-6.
2000: Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; L Sulzen; Mary Ellyn Witt; R W Weichselbaum; Everett E Vokes
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):721-8.
2000: Everett E Vokes; Merrill S Kies; Daniel J Haraf; Kerstin M Stenson; Marcy A List; Rod A Humerickhouse; M Eileen Dolan; Harold Pelzer; L Sulzen; Mary Ellyn Witt; Y C Hsieh; Bharat B Mittal; Ralph R Weichselbaum
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
2000: Kerstin M Stenson; Ellen MacCracken; Marcy A List; Daniel J Haraf; Bruce E Brockstein; R Weichselbaum; Everett E Vokes
Swallowing function in patients with head and neck cancer prior to treatment.
Archives of otolaryngology--head & neck surgery 2000;126(3):371-7.
2000: Marcy A List; John Stracks; Linda H Colangelo; P Butler; N Ganzenko; Donna S Lundy; P Sullivan; Daniel J Haraf; Merrill S Kies; W Jarrard Goodwin; Everett E Vokes
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):877-84.
2000: Mark K Ferguson; J Wang; Philip C Hoffman; Daniel J Haraf; J Olak; Gregory A Masters; Everett E Vokes
Sex-associated differences in survival of patients undergoing resection for lung cancer.
The Annals of thoracic surgery 2000;69(1):245-9; discussion 249-50.
1999: L S Johnson; BD Milliken; Scott W Hadley; Charles A Pelizzari; Daniel J Haraf; George T Y Chen
Initial clinical experience with a video-based patient positioning system.
International journal of radiation oncology, biology, physics 1999;45(1):205-13.
1999: M M Lee; Everett E Vokes; A Rosen; Mary Ellyn Witt; Ralph R Weichselbaum; Daniel J Haraf
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
The cancer journal from Scientific American 1999;5(4):219-23.
1999: J S Lee; Ashesh B Jani; Charles A Pelizzari; Daniel J Haraf; Everett E Vokes; Ralph R Weichselbaum; George T Y Chen
Volumetric visualization of head and neck CT data for treatment planning.
International journal of radiation oncology, biology, physics 1999;44(3):693-703.
1999: Everett E Vokes; Daniel J Haraf; Bruce E Brockstein; Ralph R Weichselbaum
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):70-6.
1999: Marcy A List; Amy K Siston; Daniel J Haraf; Phil L Schumm; Merrill S Kies; Kerstin M Stenson; Everett E Vokes
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1020-8.
1999: Daniel J Haraf; Merrill S Kies; Alfred W Rademaker; Kerstin M Stenson; B Mittal; Harold Pelzer; Barry L Wenig; Mary Ellyn Witt; L Sulzen; Ralph R Weichselbaum; Everett E Vokes
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
1999: Rod A Humerickhouse; M Eileen Dolan; Daniel J Haraf; Bruce E Brockstein; Kerstin M Stenson; Merrill S Kies; L Sulzen; Mark J Ratain; Everett E Vokes
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):291-8.
1998: Everett E Vokes; Bruce E Brockstein; Rod A Humerickhouse; Daniel J Haraf
Oral 5-FU alternatives for the treatment of head and neck cancer.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):35-8.
1998: Merrill S Kies; Daniel J Haraf; I Athanasiadis; Mark F. Kozloff; B Mittal; Harold Pelzer; Alfred W Rademaker; Barry L Wenig; Ralph R Weichselbaum; Everett E Vokes
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2715-21.
1998: Everett E Vokes; Ann M Mauer; Philip C Hoffman; Daniel J Haraf
Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy.
Seminars in oncology 1998;25(3 Suppl 8):28-32.
1998: Philip C Hoffman; Daniel J Haraf; Mark K Ferguson; LC Drinkard; Everett E Vokes
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):647-51.
1998: Gregory A Masters; Daniel J Haraf; Philip C Hoffman; LC Drinkard; Stuart A Krauss; Mark K Ferguson; J Olak; Brian L Samuels; HM Golomb; Everett E Vokes
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2157-63.
1998: Joseph A Toljanic; M Ali; Daniel J Haraf; Everett E Vokes; W J Moran; L Graham
Osteoradionecrosis of the jaws as a risk factor in radiotherapy: a report of an eight-year retrospective review.
Oncology reports 1998;5(2):345-9.
1998: Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; AA Fasanmade; R Stupp; B Glisson; S M Lippman; Mark J Ratain; L Sulzen; A Klepsch; Ralph R Weichselbaum; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):735-44.
1998: Ann M Mauer; Gregory A Masters; Daniel J Haraf; Philip C Hoffman; S M Watson; HM Golomb; Everett E Vokes
Phase I study of docetaxel with concomitant thoracic radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):159-64.
1997: Everett E Vokes; Gregory A Masters; Ann M Mauer; Daniel J Haraf; Philip C Hoffman; HM Golomb
Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.
Seminars in oncology 1997;24(4 Suppl 14):S14-26-S14-29.
1997: Marcy A List; P Mumby; Daniel J Haraf; Amy K Siston; R Mick; Ellen MacCracken; Everett E Vokes
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(3):274-84.
1997: Daniel J Haraf; Kerstin M Stenson; Marcy A List; Mary Ellyn Witt; Ralph R Weichselbaum; Everett E Vokes
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-68-S2-71.
1996: Daniel J Haraf; Ralph R Weichselbaum; Everett E Vokes
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):913-8.
1996: Patrick Sweeney; Daniel J Haraf; Wendy Recant; E L Kaplan; Everett E Vokes
Anaplastic carcinoma of the thyroid.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(7):739-44.
1996: Marcy A List; Linda L D'Antonio; David Cella; Amy K Siston; P Mumby; Daniel J Haraf; Everett E Vokes
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.
Cancer 1996;77(11):2294-301.
1996: Everett E Vokes; R Mick; Merrill S Kies; M Eileen Dolan; D Malone; I Athanasiadis; Daniel J Haraf; Mark F. Kozloff; Ralph R Weichselbaum; Mark J Ratain
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1663-71.
1996: Daniel J Haraf; Edwardine Nodzenski; D Brachman; R Mick; A Montag; D Graves; Everett E Vokes; Ralph R Weichselbaum
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):755-62.
1996: Everett E Vokes; Daniel J Haraf; Gregory A Masters; Philip C Hoffman; LC Drinkard; M Ferguson; J Olak; Sylvia Watson; HM Golomb
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Seminars in oncology 1996;23(2 Suppl 5):48-52.
1996: S A Pelizzari; R Grzeszczuk; George T Y Chen; R Heimann; Daniel J Haraf; Srinivasan Vijayakumar; M J Ryan
Volumetric visualization of anatomy for treatment planning.
International journal of radiation oncology, biology, physics 1996;34(1):205-11.
1996: John C Roeske; F T Kuchnir; Arno J Mundt; Daniel J Haraf
Electron-photon field matching in the treatment of paranasal sinus tumors: a case report.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1996;21(1):31-6.
1995: Y Lu; P Y Song; S D Li; Danny Spelbring; Srinivasan Vijayakumar; Daniel J Haraf; George T Y Chen
A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy.
International journal of radiation oncology, biology, physics 1995;33(5):1121-5.
1995: Everett E Vokes; Daniel J Haraf; Kerstin M Stenson; R Stupp; D Malone; J Levin; Ralph R Weichselbaum
The role of paclitaxel in the treatment of head and neck cancer.
Seminars in oncology 1995;22(5 Suppl 12):8-12.
1995: Daniel J Haraf; S J Rubin; Patrick J Sweeney; F T Kuchnir; H G Sutton; Gerald Chodak; Ralph R Weichselbaum
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(1):3-14.
1995: Everett E Vokes; R Stupp; Daniel J Haraf; W Moran; D Malone; Barry L Wenig; P Sweeney; Ralph R Weichselbaum
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1995;22(3 Suppl 6):47-52.
1995: Everett E Vokes; Merrill S Kies; Daniel J Haraf; R Mick; W J Moran; Mark F. Kozloff; B Mittal; Harold Pelzer; Barry L Wenig; WR Panje
Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):876-83.
1995: Mark K Ferguson; LAURIE REEDER; Philip C Hoffman; Daniel J Haraf; LC Drinkard; Everett E Vokes
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction.
Annals of surgical oncology 1995;2(2):101-6.
1995: WR Panje; A J Namon; E Vokes; Daniel J Haraf; R R Weichselbaum
Surgical management of the head and neck cancer patient following concomitant multimodality therapy.
The Laryngoscope 1995;105(1):97-101.
1995: Daniel J Haraf; Ralph R Weichselbaum; Everett E Vokes
Timing and sequencing of chemoradiotherapy.
Cancer treatment and research 1995;74():173-98.
1995: Ralph R Weichselbaum; Michael A Beckett; Everett E Vokes; D G Brachman; Daniel J Haraf; Dennis E Hallahan; Donald Kufe
Cellular and molecular mechanisms of radioresistance.
Cancer treatment and research 1995;74():131-40.
1995: Everett E Vokes; Daniel J Haraf; LC Drinkard; Philip C Hoffman; Mark K Ferguson; Nicholas J Vogelzang; Sylvia Watson; N J Lane; HM Golomb
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Cancer chemotherapy and pharmacology 1995;35(4):304-12.
1994: P J Meechan; Daniel J Haraf; Alan M Diamond; David J Grdina
Varying levels of radioprotection from the effects of JANUS neutrons in repair-deficient xrs-5 hamster cells treated with azacytidine.
Radiation research 1994;140(3):437-40.
1994: Everett E Vokes; Daniel J Haraf; R Mick; J M McEvilly; Ralph R Weichselbaum
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2351-9.
1994: Everett E Vokes; LC Drinkard; Brian L Samuels; Philip C Hoffman; Sylvia Watson; Jacob Bitran; Daniel J Haraf; M F Ferguson; HM Golomb
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Seminars in oncology 1994;21(5 Suppl 10):79-83; discussion 83-4.
1994: Patrick Sweeney; Daniel J Haraf; Everett E Vokes; M Dougherty; Ralph R Weichselbaum
Radiation therapy in head and neck cancer: indications and limitations.
Seminars in oncology 1994;21(3):296-303.
1994: W W Wong; R Mick; Daniel J Haraf; Ralph R Weichselbaum; Everett E Vokes
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
International journal of radiation oncology, biology, physics 1994;29(1):153-62.
1994: Everett E Vokes; Daniel J Haraf; Philip C Hoffman; Jacob Bitran; Mark K Ferguson; HM Golomb
Concomitant chemoradiotherapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S253-61.
1993: D G Brachman; Michael A Beckett; D Graves; Daniel J Haraf; Everett E Vokes; Ralph R Weichselbaum
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
Cancer research 1993;53(16):3667-9.
1993: A Rosen; Everett E Vokes; N Scher; Daniel J Haraf; Ralph R Weichselbaum; WR Panje
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
Archives of otolaryngology--head & neck surgery 1993;119(7):743-6.
1993: Everett E Vokes; Mark J Ratain; R Mick; J M McEvilly; Daniel J Haraf; Mark F. Kozloff; V Hamasaki; Ralph R Weichselbaum; WR Panje; Barry L Wenig
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):360-8.
1993: Everett E Vokes; Daniel J Haraf; Philip C Hoffman
Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.
Cancer chemotherapy and pharmacology 1993;33(3):203-9.
1992: D G Brachman; D Graves; Everett E Vokes; Michael A Beckett; Daniel J Haraf; A Montag; E Dunphy; R Mick; D Yandell; Ralph R Weichselbaum
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Cancer research 1992;52(17):4832-6.
1992: Everett E Vokes; Daniel J Haraf; Ralph R Weichselbaum; J M McEvilly; H G Sutton; WR Panje
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
Seminars in oncology 1992;19(4 Suppl 11):47-56.
1992: Daniel J Haraf; Steven M Devine; D C Ihde; Everett E Vokes
The evolving role of systemic therapy in carcinoma of the lung.
Seminars in oncology 1992;19(4 Suppl 11):72-87.
1992: Everett E Vokes; Ralph R Weichselbaum; R Mick; J M McEvilly; Daniel J Haraf; WR Panje
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Journal of the National Cancer Institute 1992;84(11):877-82.
1992: Everett E Vokes; Daniel J Haraf; WR Panje; Richard L Schilsky; Ralph R Weichselbaum
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Seminars in oncology 1992;19(3 Suppl 9):53-8.
1992: Daniel J Haraf; Everett E Vokes; Ralph R Weichselbaum; WR Panje
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
The Laryngoscope 1992;102(6):630-6.
1992: Everett E Vokes; J A Moormeier; Mark J Ratain; Merrill J Egorin; Daniel J Haraf; R Mick; Ralph R Weichselbaum
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
Cancer chemotherapy and pharmacology 1992;29(3):178-84.
1992: Everett E Vokes; Daniel J Haraf; J M McEvilly; R Mick; Mark F. Kozloff; M D Goldman; W J Moran; N J Clendeninn; M A Collier; Ralph R Weichselbaum
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(1):79-81.
1992: Daniel J Haraf; F T Kuchnir; S Watson-Bullock; D Brachman; M Doughtery; S Rubin; H Sutton
A dosimetric study comparing three-, four-, and six- field plans for treatment of carcinoma of the prostate.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1992;17(4):191-8.
1992: P J Meechan; Daniel J Haraf; Alan M Diamond; David J Grdina
Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065.
International journal of radiation oncology, biology, physics 1992;23(5):999-1002.
1991: Daniel J Haraf; Everett E Vokes; WR Panje; Ralph R Weichselbaum
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
American journal of clinical oncology 1991;14(5):419-26.
1991: Daniel J Haraf; D R Drucker; Ralph R Weichselbaum; Alan M Diamond
Radioresistant derivatives of radiosensitive CHO cells obtained following treatment with 5-azacytidine retain their sensitivity to cisplatin.
Radiation research 1991;127(2):226-9.
1991: Howard J Halpern; D R Jaffe; T D Nguyen; Daniel J Haraf; D P Spencer; M K Bowman; Ralph R Weichselbaum; Alan M Diamond
Measurement of bioreduction rates of cells with distinct responses to ionizing radiation and cisplatin.
Biochimica et biophysica acta 1991;1093(2-3):121-4.
1991: S C Springate; Daniel J Haraf; Ralph R Weichselbaum
Temporal bone chemodectomas--comparing surgery and radiation therapy.
Oncology (Williston Park, N.Y.) 1991;5(4):131-7; discussion 140, 143.
1990: John C Roeske; George T Y Chen; R W Atcher; Charles A Pelizzari; Jacob Rotmensch; Daniel J Haraf; A Montag; Ralph R Weichselbaum
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters.
International journal of radiation oncology, biology, physics 1990;19(6):1539-48.
1990: D R Jaffe; Daniel J Haraf; Jeffrey L Schwartz; Ralph R Weichselbaum; Alan M Diamond
Radioresistant derivatives of an X-ray-sensitive CHO cell line exhibit distinct patterns of sensitivity to DNA-damaging agents.
Carcinogenesis 1990;11(8):1265-9.
1990: Janet S Rader; Daniel J Haraf; Howard J Halpern; Jacob Rotmensch; Danny Spelbring; H Sutton; G Javaheri; Ralph R Weichselbaum
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
Journal of surgical oncology 1990;44(3):157-65.
1989: F T Kuchnir; J Heffron; L C Myrianthopoulos; Daniel J Haraf
Beam's-eye-view aided treatment planning for a nasopharyngeal lesion: a case report.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1989;14(4):231-5.
1988: Ralph R Weichselbaum; Michael A Beckett; M A Simon; C McCauley; Daniel J Haraf; Azhar M. Awan; Brian L Samuels; James B Nachman; A Dritschilo
In vitro radiobiological parameters of human sarcoma cell lines.
International journal of radiation oncology, biology, physics 1988;15(4):937-42.